Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B

被引：0
|
作者：
Hye Won Lee
Young Youn Cho
Hyein Lee
Jae Seung Lee
Seung Up Kim
Jun Yong Park
Do Young Kim
Sang Hoon Ahn
Beom Kyung Kim
Soo Young Park
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] Yonsei University College of Medicine,Institute of Gastroenterology
[3] Severance Hospital,Yonsei Liver Center
[4] Yonsei University Health System,Department of Internal Medicine
[5] Chung Ang University College of Medicine,Department of Internal Medicine
[6] Kyungpook National University School of Medicine,undefined
来源：
Hepatology International | 2021年 / 15卷
关键词：
Chronic hepatitis B; Entecavir; Hepatocellular carcinoma; Risk factor; Tenofovir alafenamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1083 / 1092
页数：9
相关论文
共 50 条
  • [1] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    [J]. HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1083 - 1092
  • [2] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Lee, Han Ah
    Seo, Yeon Seok
    Kim, Seung Up
    [J]. GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
  • [3] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    [J]. JOURNAL OF VIRAL HEPATITIS, 2021, 28 (11) : 1570 - 1578
  • [4] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Zhang, Hao
    Zeng, Wenting
    [J]. JAMA ONCOLOGY, 2019, 5 (06) : 914 - 915
  • [5] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B Reply
    Choi, Jonggi
    Ko, Min Jung
    Lim, Young-Suk
    [J]. JAMA ONCOLOGY, 2019, 5 (06) : 916 - 917
  • [6] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    Wong, Grace Lai-Hung
    Han, Seungbong
    Lim, Young-Suk
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87
  • [7] Comparative Effectiveness of Tenofovir vs. Entecavir in Reducing the Risk of Hepatocellular Carcinoma in a US Cohort of Patients with Chronic Hepatitis B Virus Infection
    Kramer, Jennifer R.
    Mittal, Sahil
    Richardson, Peter
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. HEPATOLOGY, 2015, 62 : 335A - 336A
  • [8] COMPARATIVE EFFECTIVENESS OF TENOFOVIR VS. ENTECAVIR IN REDUCING THE RISK OF HEPATOCELLULAR CARCINOMA IN A US COHORT OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
    Kramer, Jennifer R.
    Kim, Hyunseok
    Christie, Israel
    Richardson, Peter
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1320 - S1320
  • [9] ENTECAVIR VS. TENOFOVIR IN PREVENTION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B: SYSTEMATIC REVIEW AND META-ANALYSIS
    Kamal, Faisal
    Khan, Muhammad Ali
    Marella, Hemnishil K.
    Bayoumi, Mahmoud
    Arshad, Hafiz Muhammad Sharjeel
    Mude, Pooja J.
    Waters, Bradford
    Nair, Satheesh
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1289 - S1289
  • [10] Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
    Hsu, Yao-Chun
    Ho, Hsiu-J.
    Lee, Teng-Yu
    Huang, Yen-Tsung
    Wu, Ming-Shiang
    Lin, Jaw-Town
    Wu, Chun-Ying
    El-Serag, Hashem B.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 543 - 551
12345